Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis

Overactive BladderUrinary Incontinence

Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: A retrospective analysis

J Obstet Gynaecol Res.

Schiavi MC, Faiano P, D'Oria O, Zullo MA, Muzii L, Benedetti Panici P

doi: 10.1111/jog.13541.

Overactive BladderUrinary Tract Infections (UTI)

The effect of onabotulinumtoxinA according to site of injection in patients with overactive bladder: a systematic review and meta-analysis

World J Urol.

Jo JK, Kim KN, Kim DW, Kim YT, Kim JY, Kim JY

doi: 10.1007/s00345-017-2121-6.

RECOMMENDED

Uro-Oncology

Leiomyosarcoma of the Urinary Bladder in Adult Patients: A Systematic Review of the Literature and Meta-Analysis

Urol Int.

Zieschang H, Koch R, Wirth MP, Froehner M

doi: 10.1159/000494357.

Pregnancy and ChildbirthReproductive Health

Day 5 versus Day 6 blastocyst transfers: a systematic review and meta-analysis of clinical outcomes

Hum Reprod.

Bourdon M, Pocate-Cheriet K, Finet de Bantel A, Grzegorczyk-Martin V, Amar Hoffet A, Arbo E, Poulain M, Santulli P

doi: 10.1093/humrep/dez163.

Erectile and Sexual Functions and DysfunctionsOveractive Bladder

Impact of Overactive Bladder-Wet Syndrome on Female Sexual Function: A Systematic Review and Meta-Analysis

Sex Med Rev.

Balzarro M, Rubilotta E, Mancini V, Trabacchin N, Oppezzi L, Marzi VL, Fusco F, Serati Md M

doi: 10.1016/j.sxmr.2019.05.002.

Overactive Bladder

Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

Eur Urol.

Gratzke C, van Maanen R, Chapple C, Abrams P, Herschorn S, Robinson D, Ridder A, Stoelzel M, Paireddy A, Yoon SJ, Al-Shukri S, Rechberger T, Mueller ER

doi: 10.1016/j.eururo.

Reproductive Health

A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception

Int J Gynaecol Obstet.

Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME

doi: 10.1002/ijgo.12455.

Overactive Bladder

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

Eur Urol.

Chapple CR, Cruz F, Cardozo L, Staskin D, Herschorn S, Choudhury N, Stoelzel M, Heesakkers J, Siddiqui E

doi: 10.1016/j.eururo.2019.09.024.

Lower Urinary Tract SymptomsOveractive BladderUrinary Tract Infections (UTI)

Treatment of Non-neurogenic Overactive Bladder with OnabotulinumtoxinA: Systematic Review and Meta-analysis of Prospective, Randomized, Placebo-controlled Clinical Trials

Rev Bras Ginecol Obstet.

Arruda RM, Takano CC, Girão MJBC, Haddad JM, Aleixo GF, Castro RA

doi: 10.1055/s-0038-1642631.

Related content